The important role of the SASP inflammatory response in tumor prevention was demonstrated in mouse models for hepatocellular carcinoma (HCC), where induction of senescence by p53 activation in malignant hepatocytes was shown to reduce tumor size by SASP-mediated recruitment of immune cells to the tumors [120]. The gene discussed is TP53; the disease is hepatocellular carcinoma.